• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 miR-20a、miR-27a 和 miR-126 与普通人群非酒精性脂肪性肝病的关联。

Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.

机构信息

Department of Biomedical and Analytical Sciences, Fujita Health University School of Medical Sciences, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Department of Medical Technology, Kagawa Prefectural University of Health Sciences, 281-1, Murechohara, Takamatsu, Kagawa, 761-0123, Japan.

出版信息

Sci Rep. 2019 Dec 11;9(1):18856. doi: 10.1038/s41598-019-55076-z.

DOI:10.1038/s41598-019-55076-z
PMID:31827150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6906495/
Abstract

Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity, metabolic syndrome, and type II diabetes mellitus. Recently, circulating microRNAs (miRNAs) have been proposed as useful disease biomarkers. We examined whether circulating miRNAs, such as miR-20a, miR-27a, and miR-126, were useful biomarkers for NAFLD. We conducted a cross-sectional analysis of 527 subjects aged 39 years or older who had undergone a health examination in the Yakumo Study. Of the residents, 92 were diagnosed with NAFLD using a registered medical sonographer. Serum miR-20a, miR-27a and miR-126 levels were measured by quantitative real-time PCR. We then calculated the odds ratios for serum miRNA level changes according to the severity of NAFLD using normal liver status as the reference group. Serum levels of miR-20a and 27a, but not miR-126, were significantly lower in NAFLD subjects than normal subjects. Serum miR-20a and miR-27a levels were significantly lower in both male and female severe NAFLD subjects. Logistic regression analysis showed a significant relationship between low circulating miR-20a and 27a levels and severe NAFLD. Down-regulated circulating miR-20a and 27a levels were significantly associated with severe NAFLD in the general population. Circulating miR-20a and miR-27a may be useful biomarkers for severe NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)与肥胖、代谢综合征和 2 型糖尿病密切相关。最近,循环 microRNAs(miRNAs)被认为是有用的疾病生物标志物。我们研究了循环 miRNAs,如 miR-20a、miR-27a 和 miR-126 是否可作为 NAFLD 的有用生物标志物。我们对在屋久研究中接受健康检查的 527 名年龄在 39 岁或以上的居民进行了横断面分析。其中,92 名居民被注册的医学超声医师诊断为 NAFLD。通过定量实时 PCR 测量血清 miR-20a、miR-27a 和 miR-126 水平。然后,我们根据 NAFLD 的严重程度计算了血清 miRNA 水平变化的比值比,以正常肝脏状态为参考组。与正常组相比,NAFLD 组的血清 miR-20a 和 miR-27a 水平显著降低,但 miR-126 水平无显著差异。男性和女性严重 NAFLD 患者的血清 miR-20a 和 miR-27a 水平均显著降低。logistic 回归分析显示,低循环 miR-20a 和 miR-27a 水平与严重 NAFLD 之间存在显著关系。下调的循环 miR-20a 和 miR-27a 水平与一般人群中严重的 NAFLD 显著相关。循环 miR-20a 和 miR-27a 可能是严重 NAFLD 的有用生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6906495/ec4437d18f12/41598_2019_55076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6906495/b89a958085dc/41598_2019_55076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6906495/ec4437d18f12/41598_2019_55076_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6906495/b89a958085dc/41598_2019_55076_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0af3/6906495/ec4437d18f12/41598_2019_55076_Fig2_HTML.jpg

相似文献

1
Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.循环 miR-20a、miR-27a 和 miR-126 与普通人群非酒精性脂肪性肝病的关联。
Sci Rep. 2019 Dec 11;9(1):18856. doi: 10.1038/s41598-019-55076-z.
2
Associations of serum microRNA-20a, -27a, and -103a with cognitive function in a Japanese population: The Yakumo study.血清 microRNA-20a、-27a 和 -103a 与日本人群认知功能的相关性:矢吹研究。
Arch Gerontol Geriatr. 2019 May-Jun;82:155-160. doi: 10.1016/j.archger.2019.01.007. Epub 2019 Feb 8.
3
Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.循环 microRNAs(miR-21、miR-34a、miR-122 和 miR-451)与非酒精性脂肪肝的关系。
Clin Chim Acta. 2013 Sep 23;424:99-103. doi: 10.1016/j.cca.2013.05.021. Epub 2013 May 30.
4
Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.血浆 miR-17、miR-20a、miR-20b 和 miR-122 作为 2 型糖尿病非酒精性脂肪性肝病诊断的潜在生物标志物。
Life Sci. 2018 Sep 1;208:201-207. doi: 10.1016/j.lfs.2018.07.029. Epub 2018 Jul 17.
5
The Ratio of miR-122 to miR-20a (miR-122/miR-20a) Is a Useful Minimally Invasive Biomarker for Non-Alcoholic Fatty Liver Disease Detection.miR-122 与 miR-20a 的比值(miR-122/miR-20a)是一种用于非酒精性脂肪性肝病检测的有用微创生物标志物。
Genet Test Mol Biomarkers. 2023 Aug;27(8):239-247. doi: 10.1089/gtmb.2022.0155.
6
Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.非酒精性脂肪性肝病大鼠模型中循环miR-122的纵向研究。
Clin Chim Acta. 2015 Jun 15;446:267-71. doi: 10.1016/j.cca.2015.05.002. Epub 2015 May 7.
7
Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者循环血清miR-34a和miR-122与血脂异常的关联
PLoS One. 2016 Apr 14;11(4):e0153497. doi: 10.1371/journal.pone.0153497. eCollection 2016.
8
Association of subcutaneous and visceral fat with circulating microRNAs in a middle-aged Japanese population.中年日本人群中皮下脂肪和内脏脂肪与循环微小RNA的关联
Ann Clin Biochem. 2018 Jul;55(4):437-445. doi: 10.1177/0004563217735124. Epub 2017 Nov 8.
9
Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.血清 miR-379 表达与非酒精性脂肪性肝病患者高脂血症的发生和发展有关。
PLoS One. 2020 Feb 27;15(2):e0219412. doi: 10.1371/journal.pone.0219412. eCollection 2020.
10
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.非酒精性脂肪性肝病中的循环微小RNA特征:从血清非编码RNA到肝脏组织学及疾病发病机制
Gut. 2015 May;64(5):800-12. doi: 10.1136/gutjnl-2014-306996. Epub 2014 Jun 27.

引用本文的文献

1
The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD.循环微小RNA在非酒精性脂肪性肝病的诊断、预后及个性化治疗中的应用
J Physiol Biochem. 2025 Jul 16. doi: 10.1007/s13105-025-01110-w.
2
Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies.外周血线粒体DNA拷贝数作为脂肪性肝病发生的预测指标:来自流行病学和实验研究的见解
Environ Health Prev Med. 2025;30:42. doi: 10.1265/ehpm.25-00025.
3
From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH.

本文引用的文献

1
Ratio-Based Method To Identify True Biomarkers by Normalizing Circulating ncRNA Sequencing and Quantitative PCR Data.基于比率的方法通过标准化循环 ncRNA 测序和定量 PCR 数据来识别真正的生物标志物。
Anal Chem. 2019 May 21;91(10):6746-6753. doi: 10.1021/acs.analchem.9b00821. Epub 2019 Apr 30.
2
Associations of Circulating MicroRNAs (miR-17, miR-21, and miR-150) and Chronic Kidney Disease in a Japanese Population.循环 microRNAs(miR-17、miR-21 和 miR-150)与日本人群慢性肾脏病的相关性研究。
J Epidemiol. 2020 Apr 5;30(4):177-182. doi: 10.2188/jea.JE20180233. Epub 2019 Mar 23.
3
Associations of serum microRNA-20a, -27a, and -103a with cognitive function in a Japanese population: The Yakumo study.
从脂肪肝到肝纤维化:微小RNA对非酒精性脂肪性肝病和非酒精性脂肪性肝炎的影响。
Funct Integr Genomics. 2025 Jan 31;25(1):30. doi: 10.1007/s10142-025-01544-x.
4
Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary intervention.在进行为期2年的饮食干预后,代谢功能障碍相关脂肪性肝病患者的循环微RNA谱。
J Endocrinol Invest. 2025 Apr;48(4):987-1003. doi: 10.1007/s40618-024-02499-9. Epub 2024 Nov 16.
5
miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures.用于预测脂肪移植物原发性无功能和药物性急性肝衰竭风险的微小RNA生物标志物。
Mol Cell Biochem. 2025 Apr;480(4):2573-2593. doi: 10.1007/s11010-024-05129-3. Epub 2024 Oct 18.
6
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment.循环miR-122-5p、miR-151a-3p、miR-126-5p和miR-21-5p作为代谢功能障碍相关脂肪性肝病评估的潜在预测生物标志物。
J Physiol Biochem. 2024 Aug 14. doi: 10.1007/s13105-024-01037-8.
7
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional Intervention.多面板方法包括 microRNA、炎症标志物和抑郁症状,用于代谢功能障碍相关脂肪性肝病在 2 年营养干预期间的诊断。
Nutrients. 2024 May 21;16(11):1547. doi: 10.3390/nu16111547.
8
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
9
Genetic variants rs2910164, rs4636297 and rs895819 may contribute to the onset of acute myocardial infarction in Pakistani population.遗传变异 rs2910164、rs4636297 和 rs895819 可能导致巴基斯坦人群发生急性心肌梗死。
PLoS One. 2024 Jan 2;19(1):e0296025. doi: 10.1371/journal.pone.0296025. eCollection 2024.
10
MicroRNAs and Nonalcoholic Steatohepatitis: A Review.微小 RNA 与非酒精性脂肪性肝炎:综述。
Int J Mol Sci. 2023 Sep 23;24(19):14482. doi: 10.3390/ijms241914482.
血清 microRNA-20a、-27a 和 -103a 与日本人群认知功能的相关性:矢吹研究。
Arch Gerontol Geriatr. 2019 May-Jun;82:155-160. doi: 10.1016/j.archger.2019.01.007. Epub 2019 Feb 8.
4
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.肥胖与非酒精性脂肪性肝病:从病理生理学到治疗学。
Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29.
5
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.非酒精性脂肪性肝病患者的 miRNA:系统评价和荟萃分析。
J Hepatol. 2018 Dec;69(6):1335-1348. doi: 10.1016/j.jhep.2018.08.008. Epub 2018 Aug 22.
6
Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.血浆 miR-17、miR-20a、miR-20b 和 miR-122 作为 2 型糖尿病非酒精性脂肪性肝病诊断的潜在生物标志物。
Life Sci. 2018 Sep 1;208:201-207. doi: 10.1016/j.lfs.2018.07.029. Epub 2018 Jul 17.
7
Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues.分析大鼠肝组织中非酒精性脂肪性肝病 microRNA 表达谱。
Mol Med Rep. 2018 Sep;18(3):2669-2680. doi: 10.3892/mmr.2018.9268. Epub 2018 Jul 9.
8
Influence of Overweight and Obesity on Circulating Inflammation-Related microRNA.超重和肥胖对循环炎症相关微小RNA的影响。
Microrna. 2018;7(2):148-154. doi: 10.2174/2211536607666180402120806.
9
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)中的遗传和表观遗传调控。
Int J Mol Sci. 2018 Mar 19;19(3):911. doi: 10.3390/ijms19030911.
10
Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.循环微小RNA与人类胰岛素敏感性及相关代谢危险因素的关系
Metab Syndr Relat Disord. 2018 Mar;16(2):82-89. doi: 10.1089/met.2017.0101. Epub 2018 Jan 23.